| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $154.1M | +90.4% |
| Cost of Revenue | $118.8M | +48.9% |
| Gross Profit | $35.3M | +2905.7% |
| R&D Expense | $3.6M | -0.9% |
| SG&A Expense | $52.5M | +22.3% |
| Operating Income | -$39.4M | +32.6% |
| Interest Expense | $19.3M | +47.7% |
| Income Tax | $0 | — |
| Net Income | -$65.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.5M | +69.4% |
| Accounts Receivable | $15.5M | -45.7% |
| Inventory | $163.3M | +30.9% |
| Current Assets | $270.4M | +29.5% |
| Total Assets | $348.5M | +26.1% |
| Current Liabilities | $39.3M | +29.3% |
| Total Liabilities | $196.5M | +45.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.5M | +47.0% |
| Capital Expenditures | $13.9M | +3.0% |
| Investing Cash Flow | -$13.9M | -3.0% |
| Financing Cash Flow | $108.9M | -10.1% |
| Free Cash Flow | -$73.4M | +41.7% |
| +8.0% |
| EPS (Basic) | -$0.33 | +35.3% |
| EPS (Diluted) | -$0.33 | +35.3% |
| Stockholders' Equity |
| $152.0M |
| +7.7% |